General Information of the Compound
| Compound ID |
CP0487699
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1,4:3,6-dianhydro-5-({[4-[(4-bromo-2,3- dichlorophenyl)amino]-6- (methyloxy)quinazolin-7-yl]oxy}methyl)-5- deoxy-2-O-methyl-D-glucitol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H22BrCl2N3O5
|
||||||||||||||||||
| Molecular Weight |
571.255
|
||||||||||||||||||
| Canonical SMILES |
CO[C@H]1CO[C@@H]2[C@H](COc3cc4ncnc(Nc5ccc(Br)c(Cl)c5Cl)c4cc3OC)CO[C@H]12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H22BrCl2N3O5/c1-30-16-5-12-15(27-10-28-23(12)29-14-4-3-13(24)19(25)20(14)26)6-17(16)32-7-11-8-33-22-18(31-2)9-34-21(11)22/h3-6,10-11,18,21-22H,7-9H2,1-2H3,(H,27,28,29)/t11-,18+,21-,22-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QTWKCJAINLFWKV-ZMQOCNJZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2
Protein ID: PT01142, Vascular endothelial growth factor receptor 1
Protein ID: PT00864, Vascular endothelial growth factor receptor 2